Who
Norman Payson
Director
Company insider
Files Form 4 as: Director, Progyny; Director, Apria; Director, Evolent Health; Director, Apria Healthcare Group; Director, Idenix Pharmaceuticals.
In numbers
- Trades disclosed
- 771
- Buys
- 0
- Sells
- 214
- Bought
- $0
- Sold
- $83.1M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 6 Dec 2006
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code A | —5,660 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | $40K3,203 at $12.49 | filing |
| 21 May 2026filed 26 May 2026 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —27,119 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | $40K3,203 at $12.49 | filing |
| 21 May 2026filed 26 May 2026 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —27,119 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code A | —5,660 at $0.00 | filing |
| 18 Nov 2025filed 18 Nov 2025 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code G | —50,265 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —36,224 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code M | $53K36,224 at $1.45 | filing |
| 22 May 2025filed 27 May 2025 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —30,401 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code A | —6,689 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —24,140 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code A | —6,176 at $0.00 | filing |
| 24 May 2023filed 26 May 2023 | PGNY Progynyoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —17,670 at $0.00 | filing |
| 24 May 2023filed 26 May 2023 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code A | —4,385 at $0.00 | filing |
| 15 Feb 2023filed 17 Feb 2023 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code G | —8,652 at $0.00 | filing |
| 15 Feb 2023filed 17 Feb 2023 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Code G | —8,652 at $0.00 | filing |
| 22 Dec 2022filed 27 Dec 2022 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Sold | $204K6,617 at $30.89 | filing |
| 21 Dec 2022filed 22 Dec 2022 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Sold | $209K6,617 at $31.65 | filing |
| 8 Dec 2022filed 9 Dec 2022 | PGNY ProgynyProviders & Facilities | SEC FORM 4 Sold | $19K600 at $31.86 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Head to Head Review: Progyny (NASDAQ:PGNY) vs. U.S. Physical Therapy (NYSE:USPH)PGNY · dailypolitical.com · 15 Oct 2026
0 headlines in the last 90 days name Norman Payson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.